AGP Executive Report
Last update: 10 hours agoHealth & Travel Access: Australia says it keeps reciprocal healthcare agreements with 11 countries plus the UK, Ireland, Malta and others, letting eligible visitors access Medicare-subsidised medically necessary public hospital care (but not elective treatment), with enrolment steps still required on arrival. Vaccination Push: Uttar Pradesh reports hitting 100% of its HPV vaccination target for eligible 14-year-old girls, highlighting how HPV immunisation can cut future cervical cancer risk. Digital Safety & Youth: Australia’s approach to restricting children’s social media use is being followed by other countries, as the EU moves toward limiting access for under-15s to tackle online safety concerns. Clinical Research Update: A phase 2 ALS trial of the RIPK1 inhibitor DNL788 (SAR443820) did not slow functional decline and saw more adverse events, ending support for further ALS development. Local Resilience & Recovery: The European Commission proposes €489m from the EU Solidarity Fund for storm and flooding recovery across Portugal, Spain, Italy and Malta, including rebuilding transport infrastructure and restoring essential services. Psychedelic Therapy Access: PsyAccess launched a registry-verified directory of licensed ketamine and psychedelic-assisted therapy providers across 27 European countries, showing uneven availability.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
